An updated focused review of dexmedetomidine in adults

Annals of Pharmacotherapy

Volumn 43, Issue 12, 2009, Pages 2064-2074

  Gerlach, Anthony T ^a   Murphy, Claire V ^a   Dasta, Joseph F ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

2 agonist; Dexmedetomidine; Sedation

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; CISATRACURIUM; DEXMEDETOMIDINE; FENTANYL; HALOPERIDOL; HYDROCORTISONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; KETOPROFEN; LIDOCAINE; LORAZEPAM; MEDETOMIDINE; MIDAZOLAM; NITROUS OXIDE; OPIATE; PLACEBO; PROPOFOL; REMIFENTANIL; SEVOFLURANE; VECURONIUM;

ADRENAL INSUFFICIENCY; APNEA; BLOOD PRESSURE; BRADYCARDIA; CLINICAL TRIAL; COMA; COMPARATIVE STUDY; CONTINUOUS INFUSION; COST MINIMIZATION ANALYSIS; COUGHING; CRITICALLY ILL PATIENT; DELIRIUM; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EXTUBATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEART RATE; HEART VALVE SURGERY; HEMODYNAMICS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; INCIDENCE; INTENSIVE CARE UNIT; LANGUAGE; LENGTH OF STAY; LOADING DRUG DOSE; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MEAN ARTERIAL PRESSURE; MEDLINE; MESH HEADING; NAUSEA; NEUROPROTECTION; PRIORITY JOURNAL; QT INTERVAL; REBOUND; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SIDE EFFECT; TACHYCARDIA; TREATMENT DURATION; VOMITING;

ADRENERGIC ALPHA-AGONISTS; ADULT; CLINICAL TRIALS AS TOPIC; CRITICAL ILLNESS; DELIRIUM; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECONOMICS, PHARMACEUTICAL; HUMANS; HYPNOTICS AND SEDATIVES; TIME FACTORS;

EID: 72249085956     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M310     Document Type: Review

References (48)

1. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007;41:245-252 Epub 13 Feb 2007. DOI 10.1345/aph.1H314
2. Product information. Precedex (dexmedetomidine) Lake Forrest, IL; Hospira, October 2008.
3. Wunsch H, Kahn JM, Kramer AA, Rubenfield GD. Use of intravenous infusion sedation among mechanically-ventilated patients in the United States. Crit Care Med Epub 23 Jul 2009. DOI 10.1097/CCM.0b013e3181b02eff
4. Pandharipande PP, Pun BT, Herr DL, et al. Effects of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644-2653 DOI 10.1001/jama.298.22.2644
5. Uzumcugil F, Canbay O, Celebi AH, Ozgen S. Comparison of dexmedetomidine- propofol vs fentanyl-propofol for laryngeal mask insertion. Eur J Anaesthesiol 2008;25:675-680 DOI10.1017/S0265021508004213 (Pubitemid 351914998)
6. Zeyneloglu P, Pirat A, Candan S, Kuyumcu S, Tekin I, Arslan G. Dexmedetomidine causes prolonged recovery when compared with midazolam/ fentanyl combination in outpatient shock wave lithotripsy. Eur J Clin Anaesthesiol 2008;25:961-967 DOI 10.1017/s026502108004699
7. Muller S, Borowics S, Fortis EA, et al. Clinical efficacy of dexmedetomidine alone is less than propofol for conscious sedation during ERCP. Gastrointest Endosc 2008;67:651-659 DOI 10.1016/j.gie.2007.09.041
8. Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimargolu C, Gultekin Y. A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy, a randomized controlled trial. Anesth Analg 2008;106:114-119 DOI 10.1213/01.ane.0000296453.75494.64
9. Cheung CW, Ying CLA, Chiu WK, Wong GTC, Ng KFJ, Irwin MG. A comparison of dexmedetomidine and midazolam for sedation in third molar surgery. Anaesthesia 2007;62:1132-1138 (Pubitemid 47556426)
10. Bulow NM, Barbosa NV, Rocha JB. Opioid consumption in total anesthesia is reduced with dexmedetomidine: a comparative study with remifentanil in gynecologic videolaparoscopic surgery. J Clin Anesth 2007;19:280-285 DOI 10.1016/j.jclinane.2007.01.004
11. Turgut N, Turkman A, Gokkaya S, Altan A, Hatiboglu MA. Dexmedetomidine- based versus fentanyl-based total intravenous anesthesia for lumbar laminectomy. Minerva Anaesthesiol 2008;74:469-474
12. Bekker A, Sturaitis M, Bloom M, et al. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg 2008;107:1340-1347 DOI 10.1213/ane.0b013e31817f9476
13. Turgut N, Turkmen A, Ali A, Altan A. Remifentanil-propofol vs dexmedetomidine anesthesia for surpatentorial craniotomy. Middle East J Anaesthesiol 2009;20:63-70.
14. Dotson B, Peeters MJ. Sedation with dexmedetomidine vs lorazepam in mechanically ventilated patients (letter). JAMA 2008;299:1540.
15. Wunsch H, Meltzer JS. Sedation with dexmedetomidine vs lorazepam in mechanically ventilated patients (letter). JAMA 2008;299:1540-1541
16. Barletta JF, Devlin JW. Sedation with dexmedetomidine vs lorazepam in mechanically ventilated patients (letter). JAMA 2008;299:1541-1542
17. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301:489-499 DOI 10.1001/jama.2009.56
18. Ingersioll-Weng E, Manecke GR, Thistlewaithe PA. Dexmedetomidine and cardiac arrest. Anesthesiol 2004;100:738-739
19. Shah AN, Koneru J, Nicoara A, Goldfeder LB, Thomas K, Ehlert FA. Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker; a cautionary tale. PACE 2007;30:1158-1160 (Pubitemid 47300659)
20. Videria RL, Ferreira RM. Dexmedetomidine and asystole (letter). Anesthesiol 2004;101:1479.
21. Gerlach AT, Murphy CV. Dexmedetomidine associated bradycardia leading to pulseless electrical activity: a case report and review of literature. Pharmacother. In press.
22. Gerlach AT, Dasta JF, Steinberg S, Martin LC, Cook CH. A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. J Crit Care. In press Epub 12 Aug 2009. DOI 10.1016/j.jcrc.2009.05.015
23. Ruokonen E, Parviainen I, Jakob SM, et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009;35:282-290 DOI 10.1007/s00134-008-1296-0
24. Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R. Dexmedetomidine vs haloperidol in delirious, agitated, intubated patients: a randomized open-label trial. Crit Care 2009;13:R75. DOI100.1186/cc7890
25. Bergeron N, Dubois MJ, Dumont M, Dial S, SkrobikY. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 2001;27:859-864
26. Maldonado JR, Wysong A, van der Starre PJA, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009;50:206-217
27. Ickeringill M, Shehabi Y, Adamson H, Ruettimann U. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation; hemodynamic effects and efficacy. Anaesth Intensive Care 2004;32:741-745 (Pubitemid 40081326)
28. Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 2004;38:1130-1135 DOI 10.1345/aph.1D615
29. Bhana N, Goa KL, McKellan K. Dexmedetomidine. Drugs 2000;59:63-68
30. Product information. Duraclon (clonidine hydrochloride). Newport, KY: Xanodyne Pharmaceutical, Inc., April 2009.
31. Bokesch P, Riker R, Shehabi Y. Pharmacokinetics of dexmedetomidine for long term sedation (abstract). Anesth Anal 2009;108:S298.
32. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004;30: 2188-2196 (Pubitemid 40174254)
33. Corbett SM, Rebuck JA, Greene CM, et al. Dexmedetomidine does not improve patient satisfaction when compared to propofol during mechanical ventilation. Crit Care Med 2005;33:940-945 DOI 10.1097/01.ccm.0000162565.18193.E5
34. Elbaradie S, El Mahalaway FH, Solyman AH. Dexmedetomidine vs propofol for short-term sedation of postoperative mechanically ventilated patients. J Egyptian Natl Cancer Inst 2004;16:153-158
35. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass grafting: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothor Vasc Anesth 2003;17:576-584 DOI 10.1053/s1053-0770(03)00200-3 (Pubitemid 37296621)
36. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001;87:684-690
37. Haenggi M, Ypparila-Wolters H, Hauser K, et al. Intra- and inter-individual variation of BIS-index and Entropy during controlled sedation with midazolam/remifentanil and dexmedetomidine/remifentanil in healthy volunteers: an interventional study. Crit Care 2009;13:R20. DOI 10.1186/cc7723
38. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-394 (Pubitemid 30620311)
39. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001;286:2703-2710 (Pubitemid 33135077)
40. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291:1753-1762 (Pubitemid 38489897)
41. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004;32:955-962 (Pubitemid 38471515)
42. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104:21-26
43. Thompson JS, Santini A, Peterson JF, Pun BT, Jackson JC, Ely EW. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care 2005;9:R375-81. DOI 10.1186.cc3729
44. Pandharipande P, Cotton BA, Shintini A, et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008;65:34-41. DOI 10.1097/ta.0b013e31814b2c4d
45. Maze M, Virtanen R, Daunt D, Banks SJ, Stover EP, Feldman D. Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in-vivo and in-vitro studies. Anesth Analg 1991;73:204-208
46. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenal cortical function, and the cardiovascular, endocrine, and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001;86:650-656 (Pubitemid 32409406)
47. Dasta J, Kane-Gill S. Pharmacoeconomics of ICU sedation. Crit Care Clin 2009;25:571-583 DOI 10.1016/j.ccc.2009.03.002
48. Dasta J, Kane-Gill S, Pencina M, et al. A cost-minimization analysis of dexmedetomidine compared to midazolam for long-term sedation in the intensive care unit. Crit Care Med. E pub 28 Sept 2009. DOI 10.197/ccm.obo13e3181bc81cp